The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Circulating tumor cell (CTC) as a significant clinical marker in epithelioid-type malignant pleural mesothelioma (MPM).
Kazue Yoneda
No relevant relationships to disclose
Fumihiro Tanaka
No relevant relationships to disclose
Shunichi Fukuda
No relevant relationships to disclose
Hayato Orui
No relevant relationships to disclose
Masaki Hashimoto
No relevant relationships to disclose
Teruhisa Takuwa
No relevant relationships to disclose
Yoshitomo Okumura
No relevant relationships to disclose
Seiji Matsumoto
No relevant relationships to disclose
Nobuyuki Kondo
No relevant relationships to disclose
Ayuko Sato
No relevant relationships to disclose
Tohru Tsujimura
No relevant relationships to disclose
Noriaki Tsubota
No relevant relationships to disclose
Kazuya Fukuoka
No relevant relationships to disclose
Takashi Nakano
No relevant relationships to disclose
Seiki Hasegawa
No relevant relationships to disclose